Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680667 · ClinicalTrials.gov registry record · Phase 1
Clinical Trial of Trametes Versicolor in Women With Breast Cancer
A Phase 1 study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT00680667 is a Phase 1 study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 11 participants.
The verdict
NCT00680667, a Phase 1 study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
RATIONALE: Coriolus versicolor mushroom extract may slow the growth of cancer cells and may be an effective treatment for breast cancer. PURPOSE: This phase I trial is studying the side effects and best dose of coriolus versicolor extract in treating women with stage I, stage II, or stage III breast cancer who have finished radiation therapy.
Interventions
- BIOLOGICAL Coriolus versicolor extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2007-04 |
| Est. Completion | 2011-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680667
The ClinicalTrials.gov registry entry for NCT00680667 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Coriolus versicolor extract is the first listed.
NCT00680667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680667 about?
NCT00680667 is a clinical study titled "Clinical Trial of Trametes Versicolor in Women With Breast Cancer". RATIONALE: Coriolus versicolor mushroom extract may slow the growth of cancer cells and may be an effective treatment for breast cancer. PURPOSE: This phase I trial is studying the side effects and best dose of coriolus versicolor extract in treating women with stage I, stage II, or stage III breas...
What is the current status of trial NCT00680667?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2007-04. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00680667?
The interventions under investigation include: Coriolus versicolor extract (BIOLOGICAL).
Who is sponsoring clinical trial NCT00680667?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.